The quarterly results of Indian pharma majors may not be accurately indicative of their long term future. But data regarding the demand for generic drugs clearly puts all speculations to rest. Notwithstanding regulatory hurdles in the West, Indian drug makers have a lot to benefit from the rising share of generic drugs in India too. The increasing spend on generic drugs can by itself bring in healthy revenue stream to domestic pharma majors.
No comments:
Post a Comment